Article Type : Case Report
Authors : Choayb S*, El Harras Y, Boumdine H, En-nouali H, El Fenni J and Edderai M
Keywords : Breast; Hamartoma; Ultrasonography; Magnetic resonance imaging
Breast hamartoma is an unusual benign tumour
that grows slowly over time. The present study concerns a 40-year-old
breastfeeding lady who presented with a large mass in her left breast that
gradually grew over the course of 2 years. Breast ultrasound and MRI were
favourable for breast hamartoma.
Breast hamartoma (also known as breast
fibroadenolipoma) is a benign type of breast neoplasm. It is secondary to a
benign proliferation of epithelial cells, fatty and fibrous tissues encased in
a thin capsule. Medical imaging plays a significant role in establishing the
diagnosis. The treatment modality is surgical intervention [1].
A 40-year-old lactating woman presented to the radiology department with a noticeably large, palpable mass in the left breast. She stated that it had been present for 2 years and had gradually increased in size. No history of breast lumps has been reported. During the inspection, when compared side by side, the left breast was significantly larger. No skin or nipple changes were observed, and there were no palpable axillary nodes. Breast ultrasound revealed a well-circumscribed mass with mixed echogenicity composed of fatty and fibroglandular tissue similar to that found in the normal breast (Figure 1). MRI examination revealed a well-circumscribed oval mass that was isointense to muscle on T1-weighted sequences with a few hyperintense foci. On T2-weighted sequences, the mass was heterogeneously isointense or hyperintense relative to the surrounding gland tissue. A thin, hypointense peripheral rim was detected on both sequences. No restriction on diffusion-weighted imaging (DWI) was noted. On dynamic contrast-enhanced scans, the mass appeared to be non-enhancing except for some foci showing slow, progressive enhancement (Figure 2). Mammography was not performed since our patient was breastfeeding.
Figure
1: Ultrasound
section of the left breast showing a well-encapsulated mass (arrowheads).
Breast hamartoma, also known as fibroadenolipoma, is a benign type of breast tumour. It was first described by Arrigoni et al. in 1971 as a well-circumscribed lesion composed of benign epithelial cells, adipose, and fibrous tissues. Women older than 40 years of age are most likely to be affected [1]. Hamartoma can occur in younger and older patients; however, this tumour will always develop before menopause [2]. Additionally, Venkatesh and Harish reported a case of it occurring in a 14-year-old girl. This shows that it can happen at any age [3]. Although hamartoma typically grows slowly, a faster growth rate was reported during pregnancy and lactation. Immunohistochemical similarities to normal gland tissue play a major role (positive for hormone receptors and KI67). A few rare cases have also been reported in males and in ectopic mammary tissue observed in inguinal or axillary areas [4].
Figure
2:
Breast MRI: (A) T1 and (B) T2WI showed a well-circumscribed oval mass of the
left breast, surrounded by a thin capsule, with a fat and glandular component;
(C) On dynamic post-contrast T1WI FS subtracted images, the mass did not
enhance except for some foci showing slow progressive enhancement.
Hamartomas are habitually benign, but there is a
chance that they could become cancerous. Excision and histological examination
should be used to rule out the possibility of malignant transformation. For
example, in Cowden disease, which is a rare autosomal dominant disorder caused
by mutations in the PTEN onco-suppressor gene or related genes, there is an
increased risk of breast, thyroid, and endometrial neoplasia [1-4]. In the
clinical setting, hamartoma manifests as an asymptomatic mass or unilateral
breast enlargement without a palpable lump [1]. Some bilateral forms have been
described, and the onset of signs can vary from two months to two years [2].
Their mammographic appearance is that of ovoid masses
with a heterogeneous parenchymal density consistent with both soft tissue and
lipomatous elements, bordered by a thin radiolucent halo. Benign calcifications
can be visible. Even though large hamartomas can displace adjacent tissue and
show mild compression, they do not induce architectural distortion [5]. They
also show lobular densities inside the surrounding fat, giving them a
"slice of salami" appearance. In the presence of spiculated opacities
or pleomorphic calcifications, malignancy should be suspected [3]. On
ultrasound, they appear as well-circumscribed masses with a thin peripheral
capsule. They feature a heterogenous echotexture that includes both hypoechoic
and hyperechoic areas compared to the surrounding parenchyma. On colour
Doppler, they are usually avascular and have a firm consistency on
elastography. The degree of compressibility is proportional to the amount of
adipose tissue present and is also a feature of benign breast lesions [5].
When a mammogram shows a round mass with a radiolucent
halo and an ultrasound shows an oval, heterogeneous mass surrounded by an
echogenic or echo-lucent ring, hamartoma is confirmed [1]. On MRI, all of the
mass’s constituents can be discerned on various sequences, making them easy to
diagnose. This makes it an extremely useful imaging technique. They appear very
much like another breast within the breast (the breast within the breast sign).
Since both fat and soft tissues are present, they show mixed signal intensities
on T1WI and T2WI. Typically, the rim of pseudocapsules will be hypointense.
They exhibit a gradual and progressive enhancement with a type I kinetic curve
following dynamic post-contrast. The enhancement may be similar to that of
normal breast parenchyma. They do not show restriction on DWI, and ADC values
are high. Similar to the normal breast, spectroscopy will detect water and
lactate peaks along with a low choline level [5]. Core biopsy and US-guided
needle biopsy are unable to provide a diagnosis as there are no distinctive
features capable of characterizing the lesions. However, surgical removal can
identify the typical histological characteristics [4]. Usually, total excision
is the therapy of choice, but recurrence is seen in approximately 8% of cases
that have been reported [1].
Breast hamartoma is a rare benign tumour that usually
occurs after the age of 40. Imaging helps in making the diagnosis. The risk of
malignancy is very low, but surgical resection is always indicated.
All authors contributed equally to this work.
Patient consent
Written informed patient consent for publication has
been obtained.
The authors declare that there is no conflict of
interests regarding the publication of this paper.
This research did not receive any specific subsidy
from public, commercial or not-for-profit funding organizations.